retatrutide cons Pros and Cons: What Canadians Need to Know Retatrutide, an experimental weight-loss drug,

here is a weekly printable injection schedule for Wegovy, and here is a printable weekly injection schedule for Ozempic

The current study found no differences in these risks between any GLP-1RAs, suggesting that HF benefits may be restricted to patients with significant obesity (as in STEP-HFpEF), HF benefits may emerge primarily in those with existing HF rather than for primary prevention, and/or that the mechanism of semaglutides benefit may involve weight loss rather than direct cardiac effects, say Sklepinski and McCoy

The phase 2 obesity trial for retatrutide enrolled a separate subgroup of people with obesity and NAFLD

The pivotal trials leading to FDA approval demonstrated reductions in visceral adipose tissue of approximately 15 to 20% over 26 weeks in HIV lipodystrophy patients, with continued reduction at 52 weeks